Phototron Holdings Inc (PHOT) 0.0090 $PHOT GrowLife

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Phototron Holdings Inc (PHOT) 0.0090 $PHOT

GrowLife Strengthens Its Financial Position
BusinessWire - Thu May 05, 4:22PM CDT
GrowLife, Inc. (OTCBB: PHOT), one of the nation's most recognized indoor cultivation service providers, today announced its intent to acquire Go Green Hydroponics, a Southern California hydroponic retailer, and new funding with investment firms to expand and better manage its financial needs.

Evaluating the Market Data - New Reports on GrowLife, Federal Home Loan Mortgage, South32 and GW Pharmaceuticals
ACCESSWIRE - Wed Mar 16, 6:40AM CDT
NEW YORK, NY / ACCESSWIRE / March 16, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: GrowLife Inc. (OTC: PHOT), Federal Home Loan Mortgage Corp. (OTC: FMCC), South32 Ltd. (OTC: SOUHY) and GW Pharmaceuticals PLC (OTC: GWPRF). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

GrowLife Announces Change in Board Members
BusinessWire - Wed Mar 09, 5:24PM CST
GrowLife, Inc. (OTCBBHOT), one of the nation's most recognized cultivation service providers, announced today that the GrowLife board of directors has accepted the resignation of Mr. Brad Fretti and Ms. Tara Antal, appointees approved by its secured lender. GrowLife is currently soliciting interest from qualified independent board member candidates, as agreed in the derivative agreement, filed on June 17, 2015 and found on the SEC.gov website. The SEC filing link to the qualifications may also be found on the Company's home page at www.growlifeinc.com.

NTRR Leadership Meets With Industry Stakeholders at U.S. Cannabis Cup
BusinessWire - Mon Apr 20, 6:49AM CDT
Only days after networking with the cannabis industry's leading lights at the Big Industry Show, Neutra Corp. (OTCBB:NTRR) CEO Chris Brown will meet with industry stakeholders what's being billed as the largest cannabis rally and trade show in history today to discuss new solutions and innovations at the U.S. Cannabis Cup Expo in Denver.

GrowLife Announces Proposed Settlement for Pending Securities Litigation
BusinessWire - Thu Feb 12, 8:01AM CST
GrowLife, Inc. (OTCMKTS: PHOT) announced today that on February 9, 2015, the Company and plaintiff's counsel filed a Notice of Proposed Settlement with the Court presiding over the Consolidated Class Action lawsuits filed in 2014. The parties expect to file Notices of Proposed Settlement in the Court presiding over the Derivative Actions during February, 2015. The Company anticipates that the settlements will be documented and any necessary motions for Court approval of the settlements will be filed within the next 45 days.

NTRR Joint Venture Partner S2O2 Expands into Canadian Cannabis Industry with Plant-Boosting Antimicrobial Surface Treatments
BusinessWire - Thu Jan 15, 10:55AM CST
Neutra Corp. (OTCBB: NTRR) and joint venture partner Surface to Air Solutions (S2O2) expanded into the Canadian cannabis industry this week, announcing that they are now working with a licensed cannabis grower in Canada to demonstrate that their antimicrobial surface treatments can protect indoor crops by eliminating mold, fungus, germs, bacteria, allergens and pests.

NTRR CEO: 2015 Poised to Be Another BIG Year for the Cannabis Industry
BusinessWire - Wed Jan 07, 9:19AM CST
After the U.S. cannabis industry enjoyed its biggest and most prosperous year ever in 2014, Neutra Corp. (OTCBB:NTRR) and other innovators working to capitalize on the industry's rise now look ahead to a year expected be even bigger -- and more lucrative.

NTRR: Decision to Allow Cannabis Cultivation and Sales on Indian Reservations Could Lead to More Explosive Growth in Multi-Billion-Dollar U.S. Cannabis Industry
BusinessWire - Tue Dec 16, 4:00AM CST
Neutra Corp. (OTCBB: NTRR) and other innovators working to serve the needs of the fast-growing U.S. cannabis industry received more good news last week when the Department of Justice announced that it would allow Native American tribes to cultivate and sell cannabis on their reservations--even in states where the plant remains outlawed. It's a move many experts believe could trigger a massive new wave of growth in an industry forecast to be worth as much as $35 billion by 2020.

NTRR Unveils First Portable Contain A Grow Model Unit for Indoor Cultivation
BusinessWire - Wed Dec 10, 9:18AM CST
Neutra Corp. (OTCBB:NTRR) today unveiled its first portable Contain A Grow turnkey model unit specifically designed for indoor horticulture cultivation and announced that the blooming system is ready for testing by growers in the cannabis cultivation market and other growing industries.

NTRR Opens Talks to Add Latest Technologies to Contain A Grow Indoor Horticulture Systems
BusinessWire - Wed Dec 03, 4:00AM CST
Neutra Corp. (OTCBB:NTRR) and its joint venture partner, Vertigo Technologies, announced today that they have opened talks with rising technology innovators to potentially add sophisticated new lighting and drying systems to the cutting-edge, built-to-order indoor horticultural pods now being marketed for use producing cannabis and other nutraceutical crops.

NTRR: Banking Breakthrough in Colorado a New Milestone in Booming Cannabis Industry's Rise
BusinessWire - Tue Nov 25, 8:36AM CST
In a major new milestone for the fast-growing cannabis industry, the world's first financial institution established specifically to serve cannabis businesses has been approved in Colorado. That's a huge breakthrough for companies such as Neutra Corp. (OTCBB: NTRR) that are working to serve high demand for new technology innovations in the billion-dollar U.S. cannabis market.
VSI: 27.54 (-0.97), NUTR: 25.68 (-0.03), MO: 66.20 (-0.06)

GrowLife widens loss in Q3 2014
M2 - Fri Nov 21, 3:28AM CST
GrowLife Inc (OTCHOT), a cultivation service provider, on Thursday reported net loss of USD37,766,000, for the third quarter of 2014, ended 30 September 2014.

NTRR Targets Texas, a State Expected to Lead the Nation as a Model of Medical Cannabis Reform
BusinessWire - Thu Nov 20, 8:09AM CST
Neutra Corp. (OTCBB:NTRR) has set its sights on Texas, the country's largest remaining market with no medical cannabis provisions and a state experts say could lead the nation as a model of reform.

GrowLife Announced Revenues of $2.1 Million for Third Quarter Ending September 30, 2014
BusinessWire - Thu Nov 20, 8:01AM CST
GrowLife, Inc. (OTCHOT), one of the largest cultivation service providers in the nation, reported today in its latest financial statement revenues of $2.1 million for the third quarter ending on September 30, 2014. GrowLife also reported gross margins were (8.5%), resulting from the Company's decision to convert its high inventory level of $1.8 million from last quarter to working capital and reduce ending inventory at $800,000. General and administrative expenses were $1.9 million for the quarter, which included approximately $1.1 million in non-cash stock expenses.

NTRR CEO: 'Historic' Federal Hearing Could Be Beginning of the End of Cannabis Prohibition
BusinessWire - Tue Nov 18, 4:00AM CST
A federal hearing underway in California challenging cannabis' Schedule I DEA classification could lead to the current nationwide ban being declared unconstitutional, which would expand the consumer base for companies like Neutra Corp. (OTCBB:NTRR) that offer ancillary products to the marketplace.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 113

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 352

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 377

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 225

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 416

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 115

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 349

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 266

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Scent Dispensing Solution for Hunting Enthusiasts

Updated Category News Views 168

Introducing a Game-Changing Scent Dispensing System In the world of hunting, attracting game animals can often be a challenge. A new invention, designed specifically for this purpose, promises to make the process much simpler and more efficient. The inventor of this innovative scent dispensing system, THE DRAG LINE PRO, envisioned a better way to utilize a scent drag...

Continue Reading
Corby Spirit and Wine Limited Reports Impressive Fiscal Results

Updated Category News Views 295

Corby Spirit and Wine Limited Announces Strong Fiscal Performance Corby Spirit and Wine Limited, renowned for its position as a leading Canadian manufacturer, marketer, and importer of spirits, has recently unveiled impressive results for its fourth quarter and full-year fiscal 2025. The company demonstrated significant growth in revenue, achieving total revenues of...

Continue Reading
Sezzle Faces Setback as Short-Seller Targets Its Practices

Updated Category News Views 113

Sezzle's Stock Takes a Dramatic Hit Recently, the buy now, pay later (BNPL) provider Sezzle experienced a significant decrease in its stock value. Reports indicate that shares fell over 28.6% in early trading after Hindenburg Research disclosed a short position against the company due to concerns surrounding risky lending practices. Understanding the Short-Selling...

Continue Reading
Exploring the Growth of $1000 in Marsh & McLennan Cos Today

Updated Category News Views 116

Understanding Long-Term Investment in Marsh & McLennan Marsh & McLennan Cos (NYSE: MMC) has established itself as a financial powerhouse, outperforming the market consistently over the past two decades. Investors have experienced an impressive annualized return of 13.31%, showcasing the benefits of long-term investment strategies. The Value of Persistence in Investing...

Continue Reading
Discover Toll Brothers' Latest Luxury Homes at Overbrook Estates

Updated Category News Views 671

Introducing Overbrook Estates by Toll Brothers Toll Brothers, Inc. (NYSE:TOL), a renowned name in luxury homebuilding, excitedly unveils its newest community: Overbrook Estates. This anticipated project is set to grace the Huntersville area, offering homebuyers elegant living in a master-planned environment. Positioned conveniently off Highway 77, this prime location sets...

Continue Reading